<DOC>
	<DOC>NCT00625833</DOC>
	<brief_summary>This is a trial to investigate the effectiveness and safety of [S,S]-Reboxetine in relieving chronic peripheral pain suffered by patients with diabetes. Some evidence for the effectiveness of [S,S]- Reboxetine in relieving chronic pain has been seen in 3 completed trials.</brief_summary>
	<brief_title>A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Male or female of any race at least 18 years of age Diagnosis of painful, distal, symmetrical, sensorymotor polyneuropathy, which is due to diabetes, for at least 1 year Patients at Visit 1 must have a score â‰¥40 mm on the Pain Visual Analogue Scale Patients with significant hepatic impairment Neurological disorders unrelated to diabetic neuropathy that may confuse the assessment of neuropathic pain Any pain or other condition that may confound assessment or selfevaluation of the pain due to diabetic neuropathy Amputations other than toes A current or recent diagnosis (past 6 months) or episode of major depressive disorder and/or uncontrolled depression History of transient ischemic attack or stroke Myocardial infarction or unstable angina within the past three months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>